NCT01620931View on ClinicalTrials.gov

A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 7, 2011

Primary Completion Date

September 3, 2012

Study Completion Date

September 3, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Single doses, iv or sc

DRUG

RO5469754

Single ascending doses, iv or sc

Trial Locations (1)

9728 NZ

Groningen

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01620931 - A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers | Biotech Hunter | Biotech Hunter